Growth Opportunities in Pharmacovigilance and Safety Testing
Opportunities in Revenue Cycle Management (RCM) Operations
- Capitalize on preventive care models to drive laboratory growth.
- How can automation enhance operational efficiency?
- Leverage growth in CGT by adopting vivo gene therapies.
- How will gene-editing approvals drive commercialization?
- Adopt best practices to navigate policy changes reshaping pharma.
- What growth opportunities arise in biosimilar production?
- Are you prepared to thrive amid the ADC revolution?
- Assess contract development & manufacturing organizations.
- Capture key growth avenues in synthetic biology.
- What best practices help adopt GenAI to improve outcomes?
- Harness AI-driven imaging for precision immunomodulation.
- Which innovations are driving growth in healthcare?
Introducing Frost & Sullivan’s Healthcare and Life Sciences LinkedIn Page
Transformation Growth Perspectives
Explore our growth-oriented whitepapers that translate industry disruption and strategic imperatives into actionable growth opportunities, competitive benchmarking, companies-to-action, and best practices to accelerate performance and drive sustainable competitive advantage.
Explore Executive Perspectives on Business Transformation
Interview with Dr. Yaser Dezhkam
Building Resilient Biopharma Manufacturing: How Kirsch BioPharm Is Redefining Innovation, Sustainability, and Global Scale
Dr. Yaser Dezhkam
Managing Director | Kirsch BioPharm GmbH
Interview with Weena Leck
Building Resilient Biopharma Manufacturing: How Kirsch BioPharm Is Redefining Innovation, Sustainability, and Global Scale
Weena Leck
Managing Director | Kirsch Pharma Asia-Pacific
Interview with Dr. Vasu Rangadass
Reimagining LIMS: How L7 Informatics Is Accelerating the Next Wave of Digital Transformation
Dr. Vasu Rangadass
Founder and Strategy Officer | L7 Informatics
Interview with Vijay Ramanathan
RamSoft’s Transformational Growth Strategy: AI, Cloud, and the Future of Imaging
Vijay Ramanathan
CEO | Ramsoft
Interview with Dr. Chris Chen
Scaling Biologics Innovation: How WuXi Biologics Became a Global CRDMO Partner
Dr. Chris Chen
CEO | WuXi Biologics
Interview with Angel Alberich-Bayarri
From Pixels to Biomarkers: How Quibim Is Redefining the Future of Precision Medicine
Angel Alberich-Bayarri
CEO | Quibim
Interview with Federico Ruiz
Reimagining Patient Engagement: How Puppeteer.ai is Redefining the Digital Front Door with Agentic AI
Federico Ruiz
CEO | Puppeteer.ai
Interview with Dr. Veerapol Khemarangsan
From Biobank to Biopharmaceutical: How MEDEZE Is Building the Future of Regenerative Medicine
Dr. Veerapol Khemarangsan
CEO | MEDEZE
Interview with Prashant Warier
Reimagining Global Healthcare: How Qure.ai is Scaling AI to a Billion Lives
Prashant Warier
Co-founder and CEO | Qure.ai
Interview with William Moss
Democratizing Real-world Evidence: How 3Aware is Empowering MedTech Innovators
William Moss
CEO | 3Aware
Interview with Phillip Stoltzfus
Democratizing Real-world Evidence: How 3Aware is Empowering MedTech Innovators
Phillip Stoltzfus
VP of Marketing & Public Relations | 3Aware
Interview with John Moller
Shaping the Future of Biotech Trials: An Interview with John Moller, CEO of Novotech
John Moller
CEO | Novotech
Interview with Srulik Dvorsky
Transforming Healthcare Affordability: An Exclusive Interview with Srulik Dvorsky, CEO & Co-Founder of TailorMed
Srulik Dvorsky
CEO & Co-founder | TailorMed
Interview with Yvonne Lungershausen
The Future of Biotech CROs: An Exclusive Interview with Yvonne Lungershausen, CEO, Avance Clinical
Yvonne Lungershausen
CEO | Avance Clinical
How can your organization thrive amidst the transformation of the ever-evolving NG911 and 5G industries?
Next Generation 911 in the United States
- How can you address growth gaps to outperform competitors in public safety?
- Capitalize on key prospects by aligning organizational design with innovations.
- Identify opportunities reshaping the next generation 911 (NG911) landscape.
Private 5G Network Landscape
- Are you equipped with new technologies to thrive amidst transformation?
- Maximize growth by harnessing networks to enhance performance.
- Align your strategy with megatrends reshaping private 5G networks.
Which growth prospects are emerging due to investments in healthcare IT and developments in the healthcare cloud?

Learn more

Learn more

Learn more
Frost & Sullivan Brand and Demand Solutions

Which medical technologies are pioneering a connected, personalized, and sustainable healthcare ecosystem?
The Growth Innovation Leadership Council
How can your team grow rapidly in the ABM platform, content delivery network, and cloud service industries?
Innovaccer Receives Frost & Sullivan’s 2026 United States New Product Innovation Recognition for Excellence in AI-Driven Patient Access Solutions
Frost & Sullivan is pleased to announce that Innovaccer has received the 2026 United States New Product Innovation Recognition in the United States Patient Access Solutions Industry for its outstanding achievements in innovation, strategy execution, and customer impact.
Philips Receives Frost & Sullivan’s 2025 Global Enabling Technology Leadership Recognition for Excellence in Digital Pathology–Healthcare Informatics
Frost & Sullivan is pleased to announce that Philips has been awarded the 2025 Global Enabling Technology Leadership Recognition in the Digital Pathology–Healthcare Informatics sector for its outstanding achievements in delivering next-generation digital pathology innovation, accelerated workflow modernization, and clinical informatics.
How NEUCA Is Transforming European Pharmaceutical Supply Chains Through a CDMO-led Model of Flexibility, Efficiency, and Trust
In this Movers & Shakers conversation, Tomasz Nawrocki, Group Contract Manufacturing & Services Director at NEUCA, discusses how NEUCA’s CDMO and services platform is evolving to meet these challenges, by focusing on operational flexibility, targeted manufacturing niches, and deep, long-term customer relationships.
From AI Experimentation to Execution: How Digital Protocols Defined SCOPE Summit 2026
Held from 2–5 February 2026 in Orlando, Florida, SCOPE Summit 2026 marked a decisive turning point for the clinical research ecosystem. What was once discussed as future potential; AI in clinical trials, connected data environments, and patient-centric execution, is now being operationalized at scale.
Cell Therapy’s Full-chain Integration and Commercial Acceleration
Cell therapy, arguably the most disruptive frontier in modern biopharmaceuticals, is now seeing its industrial-scale manufacturing and commercial rollout gather unstoppable momentum. Driven by sustained advances in stem-cell and immune-cell mechanistic research, process development, and clinical validation—and under an increasingly mature global regulatory framework—the first wave of innovative products has now gained marketing approval, signaling that the field has established a full—spectrum industrial paradigm spanning discovery, manufacturing, and registration.
Check out the latest news covering key industry developments and major company highlights to stay up-to-date in the healthcare and life sciences landscape.
- Bristol Myers, Takeda to pool data for AI-based drug discovery
- Healthcare IT firm Availity to triple India tech staff by 2026 end
- Blackstone, TPG to take medtech Hologic private for $18.3 billion
- A $2.5 billion pledge makes women’s health a priority in the Gates Foundation spend-down
- Adtalem, Google Cloud to launch AI credential program for healthcare professionals
Frost & Sullivan Institute
Navigate major shifts and optimize growth strategies for the CX and WEM landscapes.
Frost Growth Expert Network
Explore a wide range of Growth Webinars and Growth Podcasts highlighting emerging opportunities in the healthcare and life sciences landscape.
CDMO Live Europe
Dates: May 19-21, 2026
Venue: Rotterdam
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series. CDMO Live connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Medical Fair India 2026
Dates: 17 – 19 September 2026
Venue: Bombay Exhibition Center, Goregaon (E), Mumbai
Medical Fair India is an international trade fair, exhibition, and conference for hospitals, health centres, and clinics. It serves as a world-class platform for industry engagement, innovation, and collaboration. The show receives strong institutional support from leading industry associations and key healthcare stakeholders, including policymakers, innovators, medical device manufacturers, hospitals, tech start-ups, and researchers.
CDMO Live Americas
Dates: October 19-21, 2026
Venue: Boston
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series. CDMO Live connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Dates: May 19-21, 2026
Venue: Rotterdam
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series that connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Register Now
Dates: October 19-21, 2026
Venue: Boston
We're partnering with CDMO Live - the pharmaceutical industry's leading external manufacturing events series that connects pharma and biotech sponsors with contract manufacturing partners through focused conference sessions, networking, and the PartnerMatch meeting program that facilitates direct CDMO-sponsor connections.
Frost & Sullivan clients receive 20% off registration with code FROST20.
Register Now
Dates: 17 – 19 September 2026
Venue: Bombay Exhibition Center, Goregaon (E), Mumbai
Medical Fair India is an international trade fair, exhibition, and conference for hospitals, health centres, and clinics. It serves as a world-class platform for industry engagement, innovation, and collaboration. The show receives strong institutional support from leading industry associations and key healthcare stakeholders, including policymakers, innovators, medical device manufacturers, hospitals, tech start-ups, and researchers.
Register Now
Growth
Let's Talk About Your Project
Examine she brother prudent add day ham. Far stairs now coming bed oppose hunted become his. You zealously departure had procuring suspicion. Books whose front would purse if be do decay. Quitting you way formerly disposed perceive ladyship are.
